HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-01-07FDA Approved: TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental ANDA for Tenofovir disoproxil fumarate from Macleods Pharmaceuticals Limited, authorizing a supplemental approva…
-
FDA approval · 2020-01-07FDA Approved: ABACAVIR AND LAMIVUDINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Abacavir and Lamivudine from Aurobindo Pharma Limited.
-
FDA approval · 2020-01-02FDA Approved: NEVIRAPINE — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for Amneal Pharmaceuticals LLC's nevirapine product, updating an already approved generic antire…
-
FDA approval · 2019-12-19FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for KALETRA (lopinavir/ritonavir) from AbbVie Inc., authorizing an update to the product labeling ba…
-
FDA approval · 2019-12-19FDA Approved: NORVIR — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for NORVIR (ritonavir) from AbbVie.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-12-19FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for KALETRA (lopinavir/ritonavir) from AbbVie, indicating an update to its labeling.
-
FDA approval · 2019-12-19FDA Approved: NORVIR — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for Norvir (ritonavir) submitted by AbbVie.
-
FDA approval · 2019-12-13FDA Approved: TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Tenofovir disoproxil fumarate from Aurobindo Pharma Limited. The approval covers this generic fo…
-
FDA approval · 2019-12-13FDA Approved: LAMIVUDINE AND ZIDOVUDINE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for Macleods' Lamivudine and Zidovudine fixed-dose combination product (ANDA090679) used to treat HI…
-
FDA approval · 2019-12-13FDA Approved: ABACAVIR — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for ABACAVIR (abacavir). This action confirms approval of a supplemental submi…
-
FDA approval · 2019-12-12FDA Approved: ABACAVIR — Supplemental Application (Cipla USA Inc.)
The FDA approved a supplemental application for abacavir from Cipla USA Inc., representing an approved supplement to an existing abacavir pr…
-
FDA approval · 2019-12-10FDA Approved: NEVIRAPINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Nevirapine submitted by Aurobindo Pharma Limited (ANDA077521).
-
FDA approval · 2019-12-03FDA Approved: ODEFSEY — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for ODEFSEY (emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide) submitted by G…
-
FDA approval · 2019-11-27FDA Approved: COMPLERA — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for COMPLERA (emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate) submi…
-
FDA approval · 2019-11-20FDA Approved: TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (Chartwell RX, LLC.)
FDA approved a supplemental application for Tenofovir disoproxil fumarate tablets from Chartwell RX, LLC. This approval authorizes the marke…
-
FDA approval · 2019-11-20FDA Approved: FOSAMPRENAVIR CALCIUM — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved the original ANDA for Fosamprenavir Calcium (generic) from Sun Pharmaceutical Industries, for treatment of HIV infection in com…
-
FDA approval · 2019-11-19FDA Approved: TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for tenofovir disoproxil fumarate from Strides Pharma Science Limited, updating/expanding the approv…
-
FDA approval · 2019-11-19FDA Approved: TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (Cipla USA Inc.)
The FDA approved Cipla USA Inc.'s supplemental application for tenofovir disoproxil fumarate.
-
FDA approval · 2019-10-29FDA Approved: SYMFI — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for SYMFI, the fixed-dose combination of efavirenz, lamivudine, and tenofovir disoproxil fumarat…
-
FDA approval · 2019-10-24FDA Approved: TIVICAY — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for TIVICAY (dolutegravir) from ViiV Healthcare Company.
-
FDA approval · 2019-10-24FDA Approved: TRIUMEQ — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for TRIUMEQ (abacavir sulfate, dolutegravir sodium, lamivudine) from ViiV Healthcare Company.
-
FDA approval · 2019-10-24FDA Approved: DOVATO — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for Dovato (dolutegravir and lamivudine) by ViiV Healthcare Company.
-
FDA approval · 2019-10-10FDA Approved: PIFELTRO — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for PIFELTRO (doravirine) submitted by Merck Sharp & Dohme LLC, finalizing changes to the product la…
-
FDA approval · 2019-10-10FDA Approved: DELSTRIGO — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for Delstrigo (doravirine/lamivudine/tenofovir disoproxil fumarate) from Merck Sharp & Dohme LLC…
-
FDA approval · 2019-10-07FDA Approved: LAMIVUDINE — Supplemental Application (Ingenus Pharmaceuticals, LLC)
FDA approved a supplemental application for lamivudine from Ingenus Pharmaceuticals, LLC, confirming authorization for a lamivudine product …